Global Human Microbiome Market Size, Status and Forecast 2020-2026

Global Human Microbiome Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Human Microbiome Revenue
1.4 Market Analysis by Type
1.4.1 Global Human Microbiome Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Gastrointestinal Tract Human Micobiome
1.4.3 Urogenital Tract Human Micobiome
1.4.4 Other
1.5 Market by Application
1.5.1 Global Human Microbiome Market Share by Application: 2020 VS 2026
1.5.2 Treatment
1.5.3 Diagnosis
1.6 Coronavirus Disease 2019 (Covid-19): Human Microbiome Industry Impact
1.6.1 How the Covid-19 is Affecting the Human Microbiome Industry
1.6.1.1 Human Microbiome Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Human Microbiome Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Human Microbiome Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Human Microbiome Market Perspective (2015-2026)
2.2 Human Microbiome Growth Trends by Regions
2.2.1 Human Microbiome Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Human Microbiome Historic Market Share by Regions (2015-2020)
2.2.3 Human Microbiome Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Human Microbiome Market Growth Strategy
2.3.6 Primary Interviews with Key Human Microbiome Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Human Microbiome Players by Market Size
3.1.1 Global Top Human Microbiome Players by Revenue (2015-2020)
3.1.2 Global Human Microbiome Revenue Market Share by Players (2015-2020)
3.1.3 Global Human Microbiome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Human Microbiome Market Concentration Ratio
3.2.1 Global Human Microbiome Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Human Microbiome Revenue in 2019
3.3 Human Microbiome Key Players Head office and Area Served
3.4 Key Players Human Microbiome Product Solution and Service
3.5 Date of Enter into Human Microbiome Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Human Microbiome Historic Market Size by Type (2015-2020)
4.2 Global Human Microbiome Forecasted Market Size by Type (2021-2026)
5 Human Microbiome Breakdown Data by Application (2015-2026)
5.1 Global Human Microbiome Market Size by Application (2015-2020)
5.2 Global Human Microbiome Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Human Microbiome Market Size (2015-2020)
6.2 Human Microbiome Key Players in North America (2019-2020)
6.3 North America Human Microbiome Market Size by Type (2015-2020)
6.4 North America Human Microbiome Market Size by Application (2015-2020)
7 Europe
7.1 Europe Human Microbiome Market Size (2015-2020)
7.2 Human Microbiome Key Players in Europe (2019-2020)
7.3 Europe Human Microbiome Market Size by Type (2015-2020)
7.4 Europe Human Microbiome Market Size by Application (2015-2020)
8 China
8.1 China Human Microbiome Market Size (2015-2020)
8.2 Human Microbiome Key Players in China (2019-2020)
8.3 China Human Microbiome Market Size by Type (2015-2020)
8.4 China Human Microbiome Market Size by Application (2015-2020)
9 Japan
9.1 Japan Human Microbiome Market Size (2015-2020)
9.2 Human Microbiome Key Players in Japan (2019-2020)
9.3 Japan Human Microbiome Market Size by Type (2015-2020)
9.4 Japan Human Microbiome Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Human Microbiome Market Size (2015-2020)
10.2 Human Microbiome Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Human Microbiome Market Size by Type (2015-2020)
10.4 Southeast Asia Human Microbiome Market Size by Application (2015-2020)
11 India
11.1 India Human Microbiome Market Size (2015-2020)
11.2 Human Microbiome Key Players in India (2019-2020)
11.3 India Human Microbiome Market Size by Type (2015-2020)
11.4 India Human Microbiome Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Human Microbiome Market Size (2015-2020)
12.2 Human Microbiome Key Players in Central & South America (2019-2020)
12.3 Central & South America Human Microbiome Market Size by Type (2015-2020)
12.4 Central & South America Human Microbiome Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Vedanta
13.1.1 Vedanta Company Details
13.1.2 Vedanta Business Overview and Its Total Revenue
13.1.3 Vedanta Human Microbiome Introduction
13.1.4 Vedanta Revenue in Human Microbiome Business (2015-2020))
13.1.5 Vedanta Recent Development
13.2 Seres Therapeutics
13.2.1 Seres Therapeutics Company Details
13.2.2 Seres Therapeutics Business Overview and Its Total Revenue
13.2.3 Seres Therapeutics Human Microbiome Introduction
13.2.4 Seres Therapeutics Revenue in Human Microbiome Business (2015-2020)
13.2.5 Seres Therapeutics Recent Development
13.3 Second Genome
13.3.1 Second Genome Company Details
13.3.2 Second Genome Business Overview and Its Total Revenue
13.3.3 Second Genome Human Microbiome Introduction
13.3.4 Second Genome Revenue in Human Microbiome Business (2015-2020)
13.3.5 Second Genome Recent Development
13.4 Rebiotix
13.4.1 Rebiotix Company Details
13.4.2 Rebiotix Business Overview and Its Total Revenue
13.4.3 Rebiotix Human Microbiome Introduction
13.4.4 Rebiotix Revenue in Human Microbiome Business (2015-2020)
13.4.5 Rebiotix Recent Development
13.5 ActoGeniX
13.5.1 ActoGeniX Company Details
13.5.2 ActoGeniX Business Overview and Its Total Revenue
13.5.3 ActoGeniX Human Microbiome Introduction
13.5.4 ActoGeniX Revenue in Human Microbiome Business (2015-2020)
13.5.5 ActoGeniX Recent Development
13.6 Enterome BioScience
13.6.1 Enterome BioScience Company Details
13.6.2 Enterome BioScience Business Overview and Its Total Revenue
13.6.3 Enterome BioScience Human Microbiome Introduction
13.6.4 Enterome BioScience Revenue in Human Microbiome Business (2015-2020)
13.6.5 Enterome BioScience Recent Development
13.7 AvidBiotics
13.7.1 AvidBiotics Company Details
13.7.2 AvidBiotics Business Overview and Its Total Revenue
13.7.3 AvidBiotics Human Microbiome Introduction
13.7.4 AvidBiotics Revenue in Human Microbiome Business (2015-2020)
13.7.5 AvidBiotics Recent Development
13.8 4D Pharma Research Ltd
13.8.1 4D Pharma Research Ltd Company Details
13.8.2 4D Pharma Research Ltd Business Overview and Its Total Revenue
13.8.3 4D Pharma Research Ltd Human Microbiome Introduction
13.8.4 4D Pharma Research Ltd Revenue in Human Microbiome Business (2015-2020)
13.8.5 4D Pharma Research Ltd Recent Development
13.9 Enterologics
13.9.1 Enterologics Company Details
13.9.2 Enterologics Business Overview and Its Total Revenue
13.9.3 Enterologics Human Microbiome Introduction
13.9.4 Enterologics Revenue in Human Microbiome Business (2015-2020)
13.9.5 Enterologics Recent Development
13.10 Metabogen
13.10.1 Metabogen Company Details
13.10.2 Metabogen Business Overview and Its Total Revenue
13.10.3 Metabogen Human Microbiome Introduction
13.10.4 Metabogen Revenue in Human Microbiome Business (2015-2020)
13.10.5 Metabogen Recent Development
13.11 Metabiomics
10.11.1 Metabiomics Company Details
10.11.2 Metabiomics Business Overview and Its Total Revenue
10.11.3 Metabiomics Human Microbiome Introduction
10.11.4 Metabiomics Revenue in Human Microbiome Business (2015-2020)
10.11.5 Metabiomics Recent Development
13.12 Ritter Pharmaceuticals
10.12.1 Ritter Pharmaceuticals Company Details
10.12.2 Ritter Pharmaceuticals Business Overview and Its Total Revenue
10.12.3 Ritter Pharmaceuticals Human Microbiome Introduction
10.12.4 Ritter Pharmaceuticals Revenue in Human Microbiome Business (2015-2020)
10.12.5 Ritter Pharmaceuticals Recent Development
13.13 Osel
10.13.1 Osel Company Details
10.13.2 Osel Business Overview and Its Total Revenue
10.13.3 Osel Human Microbiome Introduction
10.13.4 Osel Revenue in Human Microbiome Business (2015-2020)
10.13.5 Osel Recent Development
13.14 Symberix
10.14.1 Symberix Company Details
10.14.2 Symberix Business Overview and Its Total Revenue
10.14.3 Symberix Human Microbiome Introduction
10.14.4 Symberix Revenue in Human Microbiome Business (2015-2020)
10.14.5 Symberix Recent Development
13.15 Miomics
10.15.1 Miomics Company Details
10.15.2 Miomics Business Overview and Its Total Revenue
10.15.3 Miomics Human Microbiome Introduction
10.15.4 Miomics Revenue in Human Microbiome Business (2015-2020)
10.15.5 Miomics Recent Development
13.16 Symbiotix Biotherapies
10.16.1 Symbiotix Biotherapies Company Details
10.16.2 Symbiotix Biotherapies Business Overview and Its Total Revenue
10.16.3 Symbiotix Biotherapies Human Microbiome Introduction
10.16.4 Symbiotix Biotherapies Revenue in Human Microbiome Business (2015-2020)
10.16.5 Symbiotix Biotherapies Recent Development
13.17 MicroBiome Therapeutics LLC
10.17.1 MicroBiome Therapeutics LLC Company Details
10.17.2 MicroBiome Therapeutics LLC Business Overview and Its Total Revenue
10.17.3 MicroBiome Therapeutics LLC Human Microbiome Introduction
10.17.4 MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2015-2020)
10.17.5 MicroBiome Therapeutics LLC Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Human Microbiome Key Market Segments
Table 2. Key Players Covered: Ranking by Human Microbiome Revenue
Table 3. Ranking of Global Top Human Microbiome Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Human Microbiome Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Gastrointestinal Tract Human Micobiome
Table 6. Key Players of Urogenital Tract Human Micobiome
Table 7. Key Players of Other
Table 8. COVID-19 Impact Global Market: (Four Human Microbiome Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Human Microbiome Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Human Microbiome Players to Combat Covid-19 Impact
Table 13. Global Human Microbiome Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Human Microbiome Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Human Microbiome Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Human Microbiome Market Share by Regions (2015-2020)
Table 17. Global Human Microbiome Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Human Microbiome Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Human Microbiome Market Growth Strategy
Table 23. Main Points Interviewed from Key Human Microbiome Players
Table 24. Global Human Microbiome Revenue by Players (2015-2020) (Million US$)
Table 25. Global Human Microbiome Market Share by Players (2015-2020)
Table 26. Global Top Human Microbiome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome as of 2019)
Table 27. Global Human Microbiome by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Human Microbiome Product Solution and Service
Table 30. Date of Enter into Human Microbiome Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Human Microbiome Market Size by Type (2015-2020) (Million US$)
Table 33. Global Human Microbiome Market Size Share by Type (2015-2020)
Table 34. Global Human Microbiome Revenue Market Share by Type (2021-2026)
Table 35. Global Human Microbiome Market Size Share by Application (2015-2020)
Table 36. Global Human Microbiome Market Size by Application (2015-2020) (Million US$)
Table 37. Global Human Microbiome Market Size Share by Application (2021-2026)
Table 38. North America Key Players Human Microbiome Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Human Microbiome Market Share (2019-2020)
Table 40. North America Human Microbiome Market Size by Type (2015-2020) (Million US$)
Table 41. North America Human Microbiome Market Share by Type (2015-2020)
Table 42. North America Human Microbiome Market Size by Application (2015-2020) (Million US$)
Table 43. North America Human Microbiome Market Share by Application (2015-2020)
Table 44. Europe Key Players Human Microbiome Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Human Microbiome Market Share (2019-2020)
Table 46. Europe Human Microbiome Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Human Microbiome Market Share by Type (2015-2020)
Table 48. Europe Human Microbiome Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Human Microbiome Market Share by Application (2015-2020)
Table 50. China Key Players Human Microbiome Revenue (2019-2020) (Million US$)
Table 51. China Key Players Human Microbiome Market Share (2019-2020)
Table 52. China Human Microbiome Market Size by Type (2015-2020) (Million US$)
Table 53. China Human Microbiome Market Share by Type (2015-2020)
Table 54. China Human Microbiome Market Size by Application (2015-2020) (Million US$)
Table 55. China Human Microbiome Market Share by Application (2015-2020)
Table 56. Japan Key Players Human Microbiome Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Human Microbiome Market Share (2019-2020)
Table 58. Japan Human Microbiome Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Human Microbiome Market Share by Type (2015-2020)
Table 60. Japan Human Microbiome Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Human Microbiome Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Human Microbiome Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Human Microbiome Market Share (2019-2020)
Table 64. Southeast Asia Human Microbiome Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Human Microbiome Market Share by Type (2015-2020)
Table 66. Southeast Asia Human Microbiome Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Human Microbiome Market Share by Application (2015-2020)
Table 68. India Key Players Human Microbiome Revenue (2019-2020) (Million US$)
Table 69. India Key Players Human Microbiome Market Share (2019-2020)
Table 70. India Human Microbiome Market Size by Type (2015-2020) (Million US$)
Table 71. India Human Microbiome Market Share by Type (2015-2020)
Table 72. India Human Microbiome Market Size by Application (2015-2020) (Million US$)
Table 73. India Human Microbiome Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Human Microbiome Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Human Microbiome Market Share (2019-2020)
Table 76. Central & South America Human Microbiome Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Human Microbiome Market Share by Type (2015-2020)
Table 78. Central & South America Human Microbiome Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Human Microbiome Market Share by Application (2015-2020)
Table 80. Vedanta Company Details
Table 81. Vedanta Business Overview
Table 82. Vedanta Product
Table 83. Vedanta Revenue in Human Microbiome Business (2015-2020) (Million US$)
Table 84. Vedanta Recent Development
Table 85. Seres Therapeutics Company Details
Table 86. Seres Therapeutics Business Overview
Table 87. Seres Therapeutics Product
Table 88. Seres Therapeutics Revenue in Human Microbiome Business (2015-2020) (Million US$)
Table 89. Seres Therapeutics Recent Development
Table 90. Second Genome Company Details
Table 91. Second Genome Business Overview
Table 92. Second Genome Product
Table 93. Second Genome Revenue in Human Microbiome Business (2015-2020) (Million US$)
Table 94. Second Genome Recent Development
Table 95. Rebiotix Company Details
Table 96. Rebiotix Business Overview
Table 97. Rebiotix Product
Table 98. Rebiotix Revenue in Human Microbiome Business (2015-2020) (Million US$)
Table 99. Rebiotix Recent Development
Table 100. ActoGeniX Company Details
Table 101. ActoGeniX Business Overview
Table 102. ActoGeniX Product
Table 103. ActoGeniX Revenue in Human Microbiome Business (2015-2020) (Million US$)
Table 104. ActoGeniX Recent Development
Table 105. Enterome BioScience Company Details
Table 106. Enterome BioScience Business Overview
Table 107. Enterome BioScience Product
Table 108. Enterome BioScience Revenue in Human Microbiome Business (2015-2020) (Million US$)
Table 109. Enterome BioScience Recent Development
Table 110. AvidBiotics Company Details
Table 111. AvidBiotics Business Overview
Table 112. AvidBiotics Product
Table 113. AvidBiotics Revenue in Human Microbiome Business (2015-2020) (Million US$)
Table 114. AvidBiotics Recent Development
Table 115. 4D Pharma Research Ltd Business Overview
Table 116. 4D Pharma Research Ltd Product
Table 117. 4D Pharma Research Ltd Company Details
Table 118. 4D Pharma Research Ltd Revenue in Human Microbiome Business (2015-2020) (Million US$)
Table 119. 4D Pharma Research Ltd Recent Development
Table 120. Enterologics Company Details
Table 121. Enterologics Business Overview
Table 122. Enterologics Product
Table 123. Enterologics Revenue in Human Microbiome Business (2015-2020) (Million US$)
Table 124. Enterologics Recent Development
Table 125. Metabogen Company Details
Table 126. Metabogen Business Overview
Table 127. Metabogen Product
Table 128. Metabogen Revenue in Human Microbiome Business (2015-2020) (Million US$)
Table 129. Metabogen Recent Development
Table 130. Metabiomics Company Details
Table 131. Metabiomics Business Overview
Table 132. Metabiomics Product
Table 133. Metabiomics Revenue in Human Microbiome Business (2015-2020) (Million US$)
Table 134. Metabiomics Recent Development
Table 135. Ritter Pharmaceuticals Company Details
Table 136. Ritter Pharmaceuticals Business Overview
Table 137. Ritter Pharmaceuticals Product
Table 138. Ritter Pharmaceuticals Revenue in Human Microbiome Business (2015-2020) (Million US$)
Table 139. Ritter Pharmaceuticals Recent Development
Table 140. Osel Company Details
Table 141. Osel Business Overview
Table 142. Osel Product
Table 143. Osel Revenue in Human Microbiome Business (2015-2020) (Million US$)
Table 144. Osel Recent Development
Table 145. Symberix Company Details
Table 146. Symberix Business Overview
Table 147. Symberix Product
Table 148. Symberix Revenue in Human Microbiome Business (2015-2020) (Million US$)
Table 149. Symberix Recent Development
Table 150. Miomics Company Details
Table 151. Miomics Business Overview
Table 152. Miomics Product
Table 153. Miomics Revenue in Human Microbiome Business (2015-2020) (Million US$)
Table 154. Miomics Recent Development
Table 155. Symbiotix Biotherapies Company Details
Table 156. Symbiotix Biotherapies Business Overview
Table 157. Symbiotix Biotherapies Product
Table 158. Symbiotix Biotherapies Revenue in Human Microbiome Business (2015-2020) (Million US$)
Table 159. Symbiotix Biotherapies Recent Development
Table 160. MicroBiome Therapeutics LLC Company Details
Table 161. MicroBiome Therapeutics LLC Business Overview
Table 162. MicroBiome Therapeutics LLC Product
Table 163. MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2015-2020) (Million US$)
Table 164. MicroBiome Therapeutics LLC Recent Development
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Microbiome Market Share by Type: 2020 VS 2026
Figure 2. Gastrointestinal Tract Human Micobiome Features
Figure 3. Urogenital Tract Human Micobiome Features
Figure 4. Other Features
Figure 5. Global Human Microbiome Market Share by Application: 2020 VS 2026
Figure 6. Treatment Case Studies
Figure 7. Diagnosis Case Studies
Figure 8. Human Microbiome Report Years Considered
Figure 9. Global Human Microbiome Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Human Microbiome Market Share by Regions: 2020 VS 2026
Figure 11. Global Human Microbiome Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Human Microbiome Market Share by Players in 2019
Figure 14. Global Top Human Microbiome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Human Microbiome Revenue in 2019
Figure 16. North America Human Microbiome Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Human Microbiome Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Human Microbiome Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Human Microbiome Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Human Microbiome Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Human Microbiome Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Human Microbiome Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Vedanta Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Vedanta Revenue Growth Rate in Human Microbiome Business (2015-2020)
Figure 25. Seres Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Seres Therapeutics Revenue Growth Rate in Human Microbiome Business (2015-2020)
Figure 27. Second Genome Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Second Genome Revenue Growth Rate in Human Microbiome Business (2015-2020)
Figure 29. Rebiotix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Rebiotix Revenue Growth Rate in Human Microbiome Business (2015-2020)
Figure 31. ActoGeniX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. ActoGeniX Revenue Growth Rate in Human Microbiome Business (2015-2020)
Figure 33. Enterome BioScience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Enterome BioScience Revenue Growth Rate in Human Microbiome Business (2015-2020)
Figure 35. AvidBiotics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. AvidBiotics Revenue Growth Rate in Human Microbiome Business (2015-2020)
Figure 37. 4D Pharma Research Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. 4D Pharma Research Ltd Revenue Growth Rate in Human Microbiome Business (2015-2020)
Figure 39. Enterologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Enterologics Revenue Growth Rate in Human Microbiome Business (2015-2020)
Figure 41. Metabogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Metabogen Revenue Growth Rate in Human Microbiome Business (2015-2020)
Figure 43. Metabiomics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Metabiomics Revenue Growth Rate in Human Microbiome Business (2015-2020)
Figure 45. Ritter Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Ritter Pharmaceuticals Revenue Growth Rate in Human Microbiome Business (2015-2020)
Figure 47. Osel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Osel Revenue Growth Rate in Human Microbiome Business (2015-2020)
Figure 49. Symberix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Symberix Revenue Growth Rate in Human Microbiome Business (2015-2020)
Figure 51. Miomics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Miomics Revenue Growth Rate in Human Microbiome Business (2015-2020)
Figure 53. Symbiotix Biotherapies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Symbiotix Biotherapies Revenue Growth Rate in Human Microbiome Business (2015-2020)
Figure 55. MicroBiome Therapeutics LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. MicroBiome Therapeutics LLC Revenue Growth Rate in Human Microbiome Business (2015-2020)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Cytokine Inhibitor Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Cytokine Inhibitor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The development prospects of cytokine inhibitors are very broad, and these drugs have many medical applications and researches. Cytokine inhibitors can reduce The activity of cytokines, thereby inhibiting their role in immune responses and reducing The activation of immune cells and The occurrence o......

Global Microbial Growth Media Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

Microbial Growth Media is a nutrient component required by microorganisms, containing a variety of trace elements and trace elements, such as copper, iron, zinc, cobalt, manganese, etc. The global Microbial Growth Media market was valued at US$ 8007 million in 2023 and is anticipated to reach US$ 11530 million by 2030, witnessing a CAGR of 5.3% during The forecast period 2024-2030. The market for microbial growth media is essential in microbiology and biotechnology rese......

Global Protein Biochip Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 92

Protein Biochip is a small Protein array used to quickly detect a large number of unknown proteins. It works in a similar way to a DNA chip. First, a large number of known proteins (such as monoclonal antibodies) are placed on a small substrate and then exposed to and reacted with The unknown protein sample. Due to The specific binding between The antigen and The antibody, it can finally be detected by means of laser. The global Protein Biochip market was valued at US$ 145 million i......

Global Isothermal Nucleic Acid Amplification Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 103

Isothermal nucleic acid amplification is referred to isothermal nucleic acid amplification technology. And in this report, we get The statistics on reagents used in isothermal nucleic acid amplification technology. Nucleic acid isothermal amplification is a newer technique that amplifies DNA or RNA specific fragment from few copies to billion-fold copies under a one temperature condition, unlike PCR amplification that needs at least 30-35 thermal cycles to accomplish The reaction. T......

Global Microfluidics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Microfluidics market size was valued at US$ 3118.7 million in 2023. With growing demand in downstream market, the Microfluidics is forecast to a readjusted size of US$ 7707.1 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Microfluidics market. Microfluidics are expected to show stable growth in the future market. However, product differentiation, re......

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 122

According to our LPI (LP Information) latest study, the global Isothermal Nucleic Acid Amplification Technology (INAAT) market size was valued at US$ 6141.3 million in 2023. With growing demand in downstream market, the Isothermal Nucleic Acid Amplification Technology (INAAT) is forecast to a readjusted size of US$ 11250 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Isothermal Nucleic Acid Amplification Technol......

Global Cytokines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119

According to our LPI (LP Information) latest study, the global Cytokines market size was valued at US$ 203730 million in 2023. With growing demand in downstream market, the Cytokines is forecast to a readjusted size of US$ 611910 million by 2030 with a CAGR of 17.0% during review period. The research report highlights the growth potential of the global Cytokines market. Cytokines are expected to show stable growth in the future market. However, product differentiation, reducing costs, an......

Global Western Blot Imagers Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Western Blot Imagers market size was valued at US$ 406 million in 2023. With growing demand in downstream market, the Western Blot Imagers is forecast to a readjusted size of US$ 578.4 million by 2030 with a CAGR of 5.2% during review period. The research report highlights the growth potential of the global Western Blot Imagers market. Western Blot Imagers are expected to show stable growth in the future market. However, prod......

Global Procalcitonin Antibody Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125

According to our LPI (LP Information) latest study, the global Procalcitonin Antibody market size was valued at US$ million in 2023. With growing demand in downstream market, the Procalcitonin Antibody is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Procalcitonin Antibody market. Procalcitonin Antibody are expected to show stable growth in the future market. However, product di......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs